Lv1
50 积分 2026-03-02 加入
Ups and downs in PCSK9 inhibition in the cardiovascular arena: a review
1个月前
已完结
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
1个月前
已完结
PCSK9 inhibitor added to high-intensity statin therapy to prevent cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention: a randomized, double- blind, placebo-controlled, multicenter SHAWN study
1个月前
已完结
皖公网安备34019202002308
